Osteopenia and fractures associated with long-term therapy with MEK inhibitors-Reference-Cited by-同舟云学术

Osteopenia and fractures associated with long-term therapy with MEK inhibitors

Published:2018-12 Issue:6 Volume:28 Page:641-644
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Dumas Marc,Laly Pauline,Gottlieb Jérémy,Vercellino Laetitia,Paycha Frédéric,Bagot Martine,Baroudjian Barouyr,Madelaine Isabelle,Basset-Seguin Nicole,Eftekhari Pirayeh,Pagès Cécile,Lebbé Céleste,Lioté Frédéric

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference13 articles.

1. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

2. A case–control study of fractures in men with idiopathic osteoporosis: fractures are associated with older age and low cortical bone density;Ostertag;Bone,2013

3. FRAX and the assessment of fracture probability in men and women from the UK;Kanis;Osteoporos Int,2008

4. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis;Briot;Joint Bone Spine,2012

5. Diagnosis and management of osteoporosis;Ralston;Practitioner,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review;Healthcare;2024-01-02

2. A bibliometric analysis of research progress on pharmacovigilance and cancer from 2002 to 2021;Frontiers in Oncology;2023-01-25

3. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus;Neuro-Oncology;2022-07-05

4. Neuroendocrine neoplasia and bone (Review);Experimental and Therapeutic Medicine;2021-08-26

5. The Emerging Role of Ras Pathway Signaling in Pediatric Cancer;Cancer Research;2020-09-09